As AI and ICH M15 Transform Drug Development, Industry Leaders Convene to Advance Model-Informed…
FDA, Health Canada, and leading biopharma organizations to explore how artificial intelligence, quantitative modeling, and evolving regulatory expectations are reshaping drug…
Read More...
Read More...
